Pfizer Inc. (PFE) Stock Quote

Detailed Quote for Pfizer Inc. (PFE)

close 52 Week Information

52 Week High

January 17, 2012

Close: 22.17

52 Week Low

August 9, 2011

Close: 16.63

Today

Last Price
20.945

Change $
0.195

Change %
0.92%

Tick

Bid
20.94

Bid Size
45,600

Ask
20.95

Ask Size
28,300

Open
21.00

High
21.06

Low
20.90

Prev Close
21.14

Last Trade
11:51

Volume
9.44 m

52 Wk Hi
22.17

52 Wk Low
16.63

Market Cap
161 b

Ex-Div Date
2/1/12

Div Rate
0.88

Yield
4.1627

Shares
7,686,966,786

EPS (TTM)
1.28

PE Ratio
16.50

close Exchange Information Listed On New York Stock Exchange (NYE) Exchange
NYE

News and Media for Pfizer Inc. (PFE)

Sector News | Topic News

News for PFE

Thu, Feb 09, 2012

2:19 PM

Branham Law Group Investigates Pfizer for Qualitest Packaging Error Recall - Business Wire

Wed, Feb 08, 2012

8:20 AM

Blue Chip Dividend Plays Losing Appeal in 2012 - Marketwire

Tue, Feb 07, 2012

11:33 AM

Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen - PR Newswire

Mon, Feb 06, 2012

3:50 PM

St. Louis-based Carey, Danis & Lowe Announces Suit Against the Maker of Zoloft - Business Wire

Fri, Feb 03, 2012

6:36 PM

Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall - Business Wire

9:00 AM

Conditions of Growth, Economic Analysis -- Research Report on Pfizer Inc. and Boston Scientific Corporation - Marketwire

Thu, Feb 02, 2012

9:00 AM

Perception, Opportunity in Volatility - Research & Analysis on Vertex Pharmaceuticals Incorporated and Pfizer Inc. - Marketwire

Wed, Feb 01, 2012

4:23 PM

Pfizer Issues Statement On Voluntary Recall - Business Wire

8:20 AM

Pfizer and GlaxoSmithKline Optimistic on Growth Prospects - Marketwire

Tue, Jan 31, 2012

7:00 AM

Pfizer Reports Fourth-Quarter and Full-Year 2011 Results; Updates 2012 Financial Guidance - Business Wire

Fri, Jan 27, 2012

1:33 PM

U.S. Food And Drug Administration Approves Pfizer's INLYTA® (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC) - Business Wire

8:00 AM

Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia - Business Wire

Thu, Jan 26, 2012

9:01 PM

Lpath Temporarily Suspends Dosing of iSONEP in Clinical Trials Due to cGMP Compliance Issues at Contract Fill/Finish Source - Marketwire

8:00 AM

Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer's Care - Business Wire

8:00 AM

Alzheimer's Challenge 2012: Seeking New Tools to Help Improve Alzheimer's Care - PR Newswire

Mon, Jan 23, 2012

4:14 PM

Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer - Marketwire

Wed, Jan 18, 2012

8:20 AM

Big Pharma on the Lookout for Large Deals in 2012 - Marketwire

Tue, Jan 17, 2012

7:00 AM

Medivation and Pfizer Announce Results From Phase 3 Concert Trial of Dimebon in Alzheimer's Disease - Marketwire

7:00 AM

Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer's Disease - Business Wire

Thu, Jan 12, 2012

8:20 AM

General Electric and Pfizer -- Dividend Growth Plays for 2012 - Marketwire

More News for PFE >>

Tags for Pfizer Inc.

Research stocks or mutual funds related to Pfizer Inc. by keywords or tags. Find companies that have a similar focus to PFE. The keywords below have been associated to PFE by either user submission or electronic means.

natural gas price oil and gas stocks gasoline prices gas prices oil gas stocks oil and gas leasing high gas prices oil and gas companies investing natural gas oil production financial report oil and gas drilling historical crude oil prices gas pricing oil and gas jobs oil & gas natural gas prices oil and gas stock hunt oil investments oil price chart oil and gas news And Druggists' Sundries (5122) reports financial peak oil Drugs oil and gas investing oil drilling crude oil futures futures oil oil and gas oil crude oil gas oil and gas investor oil natural gas oil and gas investment oil research investor relations firms oil oil prices oil and gas production Healthcare oil and gas investments gas exploration oil times oil investment oil royalties investor relations oil and gas economics